Christakou C - Search Results

1

Addressing the post-irradiation hypothalamic-pituitary endocrine abnormalities of brain tumors in pediatric patients.

Velentza L, Tolia M, Christakou C, Nikolaou M, Zerdes I, Tsoukalas N, Hajiioannou J, Tsanadis K, Rigas G, Mitsis M, Theodorou K, Pistevou-Gombaki K, Tsekeris P, Kyrgias G. Velentza L, et al. Among authors: christakou c. J BUON. 2017 Sep-Oct;22(5):1240-1245. J BUON. 2017. PMID: 29135108 Free article.

2

Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.

Livadas S, Chaskou S, Kandaraki AA, Skourletos G, Economou F, Christou M, Boutzios G, Karachalios A, Zerva A, Xyrafis X, Christakou C, Pighou AK, Diamanti-Kandarakis E. Livadas S, et al. Among authors: christakou c. Clin Endocrinol (Oxf). 2011 Nov;75(5):698-703. doi: 10.1111/j.1365-2265.2011.04122.x. Clin Endocrinol (Oxf). 2011. PMID: 21605157

3

Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?

Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Alexandraki KI. Diamanti-Kandarakis E, et al. Hormones (Athens). 2007 Jul-Sep;6(3):210-7. Hormones (Athens). 2007. PMID: 17724005 Free article. Review.

4

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

Androulakis II, Kandaraki E, Christakou C, Karachalios A, Marinakis E, Paterakis T, Diamanti-Kandarakis E. Androulakis II, et al. Among authors: christakou c. Clin Endocrinol (Oxf). 2014 Sep;81(3):426-31. doi: 10.1111/cen.12447. Epub 2014 Apr 15. Clin Endocrinol (Oxf). 2014. PMID: 24601936

5

Structural, biochemical and non-traditional cardiovascular risk markers in PCOS.

Christakou C, Diamanti-Kandarakis E. Christakou C, et al. Curr Pharm Des. 2013;19(32):5764-74. doi: 10.2174/1381612811319320011. Curr Pharm Des. 2013. PMID: 23448483 Review.

6

Does polycystic ovary syndrome start in childhood?

Diamanti-Kandarakis E, Christakou C, Palioura E, Kandaraki E, Livadas S. Diamanti-Kandarakis E, et al. Among authors: christakou c. Pediatr Endocrinol Rev. 2008 Jun;5(4):904-11. Pediatr Endocrinol Rev. 2008. PMID: 18552753 Review.

7

Metformin in polycystic ovary syndrome.

Diamanti-Kandarakis E, Economou F, Palimeri S, Christakou C. Diamanti-Kandarakis E, et al. Among authors: christakou c. Ann N Y Acad Sci. 2010 Sep;1205:192-8. doi: 10.1111/j.1749-6632.2010.05679.x. Ann N Y Acad Sci. 2010. PMID: 20840272 Review.

8

The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond.

Economou F, Xyrafis X, Christakou C, Diamanti-Kandarakis E. Economou F, et al. Among authors: christakou c. Curr Pharm Des. 2011;17(9):908-21. doi: 10.2174/138161211795428821. Curr Pharm Des. 2011. PMID: 21418035 Review.

9

Pancreatic beta-cells dysfunction in polycystic ovary syndrome.

Diamanti-Kandarakis E, Xyrafis X, Boutzios G, Christakou C. Diamanti-Kandarakis E, et al. Among authors: christakou c. Panminerva Med. 2008 Dec;50(4):315-25. Panminerva Med. 2008. PMID: 19078872 Review.

10

Metabolic syndrome and polycystic ovary syndrome... and vice versa.

Kandaraki E, Christakou C, Diamanti-Kandarakis E. Kandaraki E, et al. Among authors: christakou c. Arq Bras Endocrinol Metabol. 2009 Mar;53(2):227-37. doi: 10.1590/s0004-27302009000200014. Arq Bras Endocrinol Metabol. 2009. PMID: 19466215 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page